Company news

Tango Therapeutics, Inc. news in 2025

Tango Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

December 16, 2025

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 25, 2025

Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

November 11, 2025

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

November 3, 2025

Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 28, 2025

Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers

October 22, 2025

Tango Therapeutics Announces $225 Million Financing

October 22, 2025

Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025

October 5, 2025

Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference

August 25, 2025

Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

August 5, 2025

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

July 21, 2025

Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer

June 26, 2025

Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

May 26, 2025

Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors

May 20, 2025

Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 11, 2025

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

April 30, 2025

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

March 24, 2025

Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights

February 27, 2025

Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences

February 19, 2025

Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference

January 29, 2025

Decks in 2025